TER's Q1 results are likely to reflect headwinds from persistent weakness in industrial automation, delayed Wi-Fi 7 ramp and flat memory test demand.
Besides Wall Street's top -and-bottom-line estimates for Teradyne (TER), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
Teradyne (TER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In the closing of the recent trading day, Teradyne (TER) stood at $73.65, denoting a +1.88% change from the preceding trading day.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Teradyne (TER) closed at $82.60 in the latest trading session, marking a -0.22% move from the prior day.
In the latest trading session, Teradyne (TER) closed at $89.95, marking a -1.15% move from the previous day.
In the latest trading session, Teradyne (TER) closed at $88.51, marking a -0.41% move from the previous day.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
In the most recent trading session, Teradyne (TER) closed at $88.87, indicating a -1.44% shift from the previous trading day.
Shares in test technology company Teradyne (TER 0.23%) declined by 21.4% in the week to Friday morning. The move comes after management updated the market on current trading conditions during its analyst day presentation on Tuesday.
Initiated a position in Teradyne at $108 due to its narrow to strong economic moat, despite not being significantly undervalued, and used a partial hedge strategy. Teradyne's revised revenue growth outlook for 2025 is 5%-10%, with mid-term growth expected at 12%-18% through 2028. Base case DCF derived Fair Value is $115.7 (33% upside from the current price); if they miss their mid-term targets by 20%-30%, Fair Value would be $90.